Randomised trial to evaluate the clinical value of intensive glucose monitoring and regulation in Myocardial Infarction.

Trial Profile

Randomised trial to evaluate the clinical value of intensive glucose monitoring and regulation in Myocardial Infarction.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Aug 2012

At a glance

  • Drugs Insulin aspart (Primary)
  • Indications Myocardial infarction
  • Focus Biomarker; Therapeutic Use
  • Acronyms BIOMArCS-2
  • Most Recent Events

    • 04 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
    • 31 Aug 2011 Planned end date (Feb 2012) added as reported by Netherlands Trial Register.
    • 31 Aug 2011 Status changed from not stated to recruiting as reported by Netherlands Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top